Global Cancer Test Market Size, Status and Forecast 2020-2026

May 2020 | 130 pages | ID: GFDBF1855053EN
QYResearch

Abstracts

This report focuses on the global Cancer Test status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Test development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Abbott
• Radient Pharmaceuticals
• BD Diagnostics
• Beckman Coulter
• BioCurex
• bioMerieux
• Cepheid
• CytoCore
• DiagnoCure
• Gen-Probe
• Genomic Health
• QIAGEN Marseille (Earlier Ipsogen)
• Myriad Genetics
• Panacea Pharmaceuticals
• Qiagen
• Siemens Heathcare Diagnostics
• Roche
• Roche(Ventana Medical Systems)
• Trovagene
• Vermillion

Market segment by Type, the product can be split into

• Laboratory Tests
• Genetic Tests
• Imaging
• Endoscopy

Market segment by Application, split into

• Bladder Cancer Test
• Breast Cancer Test
• Cervical Cancer Test
• Colorectal (Colon) Cancer Test
• Ovarian Cancer Test
• Prostate Cancer Test
• Liver Cancer Test
• Flow Cytometry
• Other Organ Specific Cancer Test

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Cancer Test status, future forecast, growth opportunity, key market and key players.
• To present the Cancer Test development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Cancer Test are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Test Revenue
1.4 Market Analysis by Type
  1.4.1 Global Cancer Test Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Laboratory Tests
  1.4.3 Genetic Tests
  1.4.4 Imaging
  1.4.5 Endoscopy
1.5 Market by Application
  1.5.1 Global Cancer Test Market Share by Application: 2020 VS 2026
  1.5.2 Bladder Cancer Test
  1.5.3 Breast Cancer Test
  1.5.4 Cervical Cancer Test
  1.5.5 Colorectal (Colon) Cancer Test
  1.5.6 Ovarian Cancer Test
  1.5.7 Prostate Cancer Test
  1.5.8 Liver Cancer Test
  1.5.9 Flow Cytometry
  1.5.10 Other Organ Specific Cancer Test
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Cancer Test Market Perspective (2015-2026)
2.2 Cancer Test Growth Trends by Regions
  2.2.1 Cancer Test Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Cancer Test Historic Market Share by Regions (2015-2020)
  2.2.3 Cancer Test Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Cancer Test Market Growth Strategy
  2.3.6 Primary Interviews with Key Cancer Test Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Cancer Test Players by Market Size
  3.1.1 Global Top Cancer Test Players by Revenue (2015-2020)
  3.1.2 Global Cancer Test Revenue Market Share by Players (2015-2020)
  3.1.3 Global Cancer Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Test Market Concentration Ratio
  3.2.1 Global Cancer Test Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Cancer Test Revenue in 2019
3.3 Cancer Test Key Players Head office and Area Served
3.4 Key Players Cancer Test Product Solution and Service
3.5 Date of Enter into Cancer Test Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Cancer Test Historic Market Size by Type (2015-2020)
4.2 Global Cancer Test Forecasted Market Size by Type (2021-2026)

5 CANCER TEST BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Cancer Test Market Size by Application (2015-2020)
5.2 Global Cancer Test Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Cancer Test Market Size (2015-2020)
6.2 Cancer Test Key Players in North America (2019-2020)
6.3 North America Cancer Test Market Size by Type (2015-2020)
6.4 North America Cancer Test Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Cancer Test Market Size (2015-2020)
7.2 Cancer Test Key Players in Europe (2019-2020)
7.3 Europe Cancer Test Market Size by Type (2015-2020)
7.4 Europe Cancer Test Market Size by Application (2015-2020)

8 CHINA

8.1 China Cancer Test Market Size (2015-2020)
8.2 Cancer Test Key Players in China (2019-2020)
8.3 China Cancer Test Market Size by Type (2015-2020)
8.4 China Cancer Test Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Cancer Test Market Size (2015-2020)
9.2 Cancer Test Key Players in Japan (2019-2020)
9.3 Japan Cancer Test Market Size by Type (2015-2020)
9.4 Japan Cancer Test Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Cancer Test Market Size (2015-2020)
10.2 Cancer Test Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Test Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Test Market Size by Application (2015-2020)

11 INDIA

11.1 India Cancer Test Market Size (2015-2020)
11.2 Cancer Test Key Players in India (2019-2020)
11.3 India Cancer Test Market Size by Type (2015-2020)
11.4 India Cancer Test Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Cancer Test Market Size (2015-2020)
12.2 Cancer Test Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Test Market Size by Type (2015-2020)
12.4 Central & South America Cancer Test Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbott
  13.1.1 Abbott Company Details
  13.1.2 Abbott Business Overview and Its Total Revenue
  13.1.3 Abbott Cancer Test Introduction
  13.1.4 Abbott Revenue in Cancer Test Business (2015-2020))
  13.1.5 Abbott Recent Development
13.2 Radient Pharmaceuticals
  13.2.1 Radient Pharmaceuticals Company Details
  13.2.2 Radient Pharmaceuticals Business Overview and Its Total Revenue
  13.2.3 Radient Pharmaceuticals Cancer Test Introduction
  13.2.4 Radient Pharmaceuticals Revenue in Cancer Test Business (2015-2020)
  13.2.5 Radient Pharmaceuticals Recent Development
13.3 BD Diagnostics
  13.3.1 BD Diagnostics Company Details
  13.3.2 BD Diagnostics Business Overview and Its Total Revenue
  13.3.3 BD Diagnostics Cancer Test Introduction
  13.3.4 BD Diagnostics Revenue in Cancer Test Business (2015-2020)
  13.3.5 BD Diagnostics Recent Development
13.4 Beckman Coulter
  13.4.1 Beckman Coulter Company Details
  13.4.2 Beckman Coulter Business Overview and Its Total Revenue
  13.4.3 Beckman Coulter Cancer Test Introduction
  13.4.4 Beckman Coulter Revenue in Cancer Test Business (2015-2020)
  13.4.5 Beckman Coulter Recent Development
13.5 BioCurex
  13.5.1 BioCurex Company Details
  13.5.2 BioCurex Business Overview and Its Total Revenue
  13.5.3 BioCurex Cancer Test Introduction
  13.5.4 BioCurex Revenue in Cancer Test Business (2015-2020)
  13.5.5 BioCurex Recent Development
13.6 bioMerieux
  13.6.1 bioMerieux Company Details
  13.6.2 bioMerieux Business Overview and Its Total Revenue
  13.6.3 bioMerieux Cancer Test Introduction
  13.6.4 bioMerieux Revenue in Cancer Test Business (2015-2020)
  13.6.5 bioMerieux Recent Development
13.7 Cepheid
  13.7.1 Cepheid Company Details
  13.7.2 Cepheid Business Overview and Its Total Revenue
  13.7.3 Cepheid Cancer Test Introduction
  13.7.4 Cepheid Revenue in Cancer Test Business (2015-2020)
  13.7.5 Cepheid Recent Development
13.8 CytoCore
  13.8.1 CytoCore Company Details
  13.8.2 CytoCore Business Overview and Its Total Revenue
  13.8.3 CytoCore Cancer Test Introduction
  13.8.4 CytoCore Revenue in Cancer Test Business (2015-2020)
  13.8.5 CytoCore Recent Development
13.9 DiagnoCure
  13.9.1 DiagnoCure Company Details
  13.9.2 DiagnoCure Business Overview and Its Total Revenue
  13.9.3 DiagnoCure Cancer Test Introduction
  13.9.4 DiagnoCure Revenue in Cancer Test Business (2015-2020)
  13.9.5 DiagnoCure Recent Development
13.10 Gen-Probe
  13.10.1 Gen-Probe Company Details
  13.10.2 Gen-Probe Business Overview and Its Total Revenue
  13.10.3 Gen-Probe Cancer Test Introduction
  13.10.4 Gen-Probe Revenue in Cancer Test Business (2015-2020)
  13.10.5 Gen-Probe Recent Development
13.11 Genomic Health
  10.11.1 Genomic Health Company Details
  10.11.2 Genomic Health Business Overview and Its Total Revenue
  10.11.3 Genomic Health Cancer Test Introduction
  10.11.4 Genomic Health Revenue in Cancer Test Business (2015-2020)
  10.11.5 Genomic Health Recent Development
13.12 QIAGEN Marseille (Earlier Ipsogen)
  10.12.1 QIAGEN Marseille (Earlier Ipsogen) Company Details
  10.12.2 QIAGEN Marseille (Earlier Ipsogen) Business Overview and Its Total Revenue
  10.12.3 QIAGEN Marseille (Earlier Ipsogen) Cancer Test Introduction
  10.12.4 QIAGEN Marseille (Earlier Ipsogen) Revenue in Cancer Test Business (2015-2020)
  10.12.5 QIAGEN Marseille (Earlier Ipsogen) Recent Development
13.13 Myriad Genetics
  10.13.1 Myriad Genetics Company Details
  10.13.2 Myriad Genetics Business Overview and Its Total Revenue
  10.13.3 Myriad Genetics Cancer Test Introduction
  10.13.4 Myriad Genetics Revenue in Cancer Test Business (2015-2020)
  10.13.5 Myriad Genetics Recent Development
13.14 Panacea Pharmaceuticals
  10.14.1 Panacea Pharmaceuticals Company Details
  10.14.2 Panacea Pharmaceuticals Business Overview and Its Total Revenue
  10.14.3 Panacea Pharmaceuticals Cancer Test Introduction
  10.14.4 Panacea Pharmaceuticals Revenue in Cancer Test Business (2015-2020)
  10.14.5 Panacea Pharmaceuticals Recent Development
13.15 Qiagen
  10.15.1 Qiagen Company Details
  10.15.2 Qiagen Business Overview and Its Total Revenue
  10.15.3 Qiagen Cancer Test Introduction
  10.15.4 Qiagen Revenue in Cancer Test Business (2015-2020)
  10.15.5 Qiagen Recent Development
13.16 Siemens Heathcare Diagnostics
  10.16.1 Siemens Heathcare Diagnostics Company Details
  10.16.2 Siemens Heathcare Diagnostics Business Overview and Its Total Revenue
  10.16.3 Siemens Heathcare Diagnostics Cancer Test Introduction
  10.16.4 Siemens Heathcare Diagnostics Revenue in Cancer Test Business (2015-2020)
  10.16.5 Siemens Heathcare Diagnostics Recent Development
13.17 Roche
  10.17.1 Roche Company Details
  10.17.2 Roche Business Overview and Its Total Revenue
  10.17.3 Roche Cancer Test Introduction
  10.17.4 Roche Revenue in Cancer Test Business (2015-2020)
  10.17.5 Roche Recent Development
13.18 Roche(Ventana Medical Systems)
  10.18.1 Roche(Ventana Medical Systems) Company Details
  10.18.2 Roche(Ventana Medical Systems) Business Overview and Its Total Revenue
  10.18.3 Roche(Ventana Medical Systems) Cancer Test Introduction
  10.18.4 Roche(Ventana Medical Systems) Revenue in Cancer Test Business (2015-2020)
  10.18.5 Roche(Ventana Medical Systems) Recent Development
13.19 Trovagene
  10.19.1 Trovagene Company Details
  10.19.2 Trovagene Business Overview and Its Total Revenue
  10.19.3 Trovagene Cancer Test Introduction
  10.19.4 Trovagene Revenue in Cancer Test Business (2015-2020)
  10.19.5 Trovagene Recent Development
13.20 Vermillion
  10.20.1 Vermillion Company Details
  10.20.2 Vermillion Business Overview and Its Total Revenue
  10.20.3 Vermillion Cancer Test Introduction
  10.20.4 Vermillion Revenue in Cancer Test Business (2015-2020)
  10.20.5 Vermillion Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Cancer Test Key Market Segments
Table 2. Key Players Covered: Ranking by Cancer Test Revenue
Table 3. Ranking of Global Top Cancer Test Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cancer Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Laboratory Tests
Table 6. Key Players of Genetic Tests
Table 7. Key Players of Imaging
Table 8. Key Players of Endoscopy
Table 9. Global Cancer Test Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Cancer Test Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Cancer Test Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Cancer Test Market Share by Regions (2015-2020)
Table 13. Global Cancer Test Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Cancer Test Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Cancer Test Market Growth Strategy
Table 19. Main Points Interviewed from Key Cancer Test Players
Table 20. Global Cancer Test Revenue by Players (2015-2020) (Million US$)
Table 21. Global Cancer Test Market Share by Players (2015-2020)
Table 22. Global Top Cancer Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Test as of 2019)
Table 23. Global Cancer Test by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Cancer Test Product Solution and Service
Table 26. Date of Enter into Cancer Test Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cancer Test Market Size by Type (2015-2020) (Million US$)
Table 29. Global Cancer Test Market Size Share by Type (2015-2020)
Table 30. Global Cancer Test Revenue Market Share by Type (2021-2026)
Table 31. Global Cancer Test Market Size Share by Application (2015-2020)
Table 32. Global Cancer Test Market Size by Application (2015-2020) (Million US$)
Table 33. Global Cancer Test Market Size Share by Application (2021-2026)
Table 34. North America Key Players Cancer Test Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Cancer Test Market Share (2019-2020)
Table 36. North America Cancer Test Market Size by Type (2015-2020) (Million US$)
Table 37. North America Cancer Test Market Share by Type (2015-2020)
Table 38. North America Cancer Test Market Size by Application (2015-2020) (Million US$)
Table 39. North America Cancer Test Market Share by Application (2015-2020)
Table 40. Europe Key Players Cancer Test Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Cancer Test Market Share (2019-2020)
Table 42. Europe Cancer Test Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Cancer Test Market Share by Type (2015-2020)
Table 44. Europe Cancer Test Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Cancer Test Market Share by Application (2015-2020)
Table 46. China Key Players Cancer Test Revenue (2019-2020) (Million US$)
Table 47. China Key Players Cancer Test Market Share (2019-2020)
Table 48. China Cancer Test Market Size by Type (2015-2020) (Million US$)
Table 49. China Cancer Test Market Share by Type (2015-2020)
Table 50. China Cancer Test Market Size by Application (2015-2020) (Million US$)
Table 51. China Cancer Test Market Share by Application (2015-2020)
Table 52. Japan Key Players Cancer Test Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Cancer Test Market Share (2019-2020)
Table 54. Japan Cancer Test Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Cancer Test Market Share by Type (2015-2020)
Table 56. Japan Cancer Test Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Cancer Test Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Cancer Test Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Cancer Test Market Share (2019-2020)
Table 60. Southeast Asia Cancer Test Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Cancer Test Market Share by Type (2015-2020)
Table 62. Southeast Asia Cancer Test Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Cancer Test Market Share by Application (2015-2020)
Table 64. India Key Players Cancer Test Revenue (2019-2020) (Million US$)
Table 65. India Key Players Cancer Test Market Share (2019-2020)
Table 66. India Cancer Test Market Size by Type (2015-2020) (Million US$)
Table 67. India Cancer Test Market Share by Type (2015-2020)
Table 68. India Cancer Test Market Size by Application (2015-2020) (Million US$)
Table 69. India Cancer Test Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Cancer Test Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Cancer Test Market Share (2019-2020)
Table 72. Central & South America Cancer Test Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Cancer Test Market Share by Type (2015-2020)
Table 74. Central & South America Cancer Test Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Cancer Test Market Share by Application (2015-2020)
Table 76. Abbott Company Details
Table 77. Abbott Business Overview
Table 78. Abbott Product
Table 79. Abbott Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 80. Abbott Recent Development
Table 81. Radient Pharmaceuticals Company Details
Table 82. Radient Pharmaceuticals Business Overview
Table 83. Radient Pharmaceuticals Product
Table 84. Radient Pharmaceuticals Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 85. Radient Pharmaceuticals Recent Development
Table 86. BD Diagnostics Company Details
Table 87. BD Diagnostics Business Overview
Table 88. BD Diagnostics Product
Table 89. BD Diagnostics Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 90. BD Diagnostics Recent Development
Table 91. Beckman Coulter Company Details
Table 92. Beckman Coulter Business Overview
Table 93. Beckman Coulter Product
Table 94. Beckman Coulter Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 95. Beckman Coulter Recent Development
Table 96. BioCurex Company Details
Table 97. BioCurex Business Overview
Table 98. BioCurex Product
Table 99. BioCurex Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 100. BioCurex Recent Development
Table 101. bioMerieux Company Details
Table 102. bioMerieux Business Overview
Table 103. bioMerieux Product
Table 104. bioMerieux Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 105. bioMerieux Recent Development
Table 106. Cepheid Company Details
Table 107. Cepheid Business Overview
Table 108. Cepheid Product
Table 109. Cepheid Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 110. Cepheid Recent Development
Table 111. CytoCore Business Overview
Table 112. CytoCore Product
Table 113. CytoCore Company Details
Table 114. CytoCore Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 115. CytoCore Recent Development
Table 116. DiagnoCure Company Details
Table 117. DiagnoCure Business Overview
Table 118. DiagnoCure Product
Table 119. DiagnoCure Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 120. DiagnoCure Recent Development
Table 121. Gen-Probe Company Details
Table 122. Gen-Probe Business Overview
Table 123. Gen-Probe Product
Table 124. Gen-Probe Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 125. Gen-Probe Recent Development
Table 126. Genomic Health Company Details
Table 127. Genomic Health Business Overview
Table 128. Genomic Health Product
Table 129. Genomic Health Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 130. Genomic Health Recent Development
Table 131. QIAGEN Marseille (Earlier Ipsogen) Company Details
Table 132. QIAGEN Marseille (Earlier Ipsogen) Business Overview
Table 133. QIAGEN Marseille (Earlier Ipsogen) Product
Table 134. QIAGEN Marseille (Earlier Ipsogen) Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 135. QIAGEN Marseille (Earlier Ipsogen) Recent Development
Table 136. Myriad Genetics Company Details
Table 137. Myriad Genetics Business Overview
Table 138. Myriad Genetics Product
Table 139. Myriad Genetics Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 140. Myriad Genetics Recent Development
Table 141. Panacea Pharmaceuticals Company Details
Table 142. Panacea Pharmaceuticals Business Overview
Table 143. Panacea Pharmaceuticals Product
Table 144. Panacea Pharmaceuticals Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 145. Panacea Pharmaceuticals Recent Development
Table 146. Qiagen Company Details
Table 147. Qiagen Business Overview
Table 148. Qiagen Product
Table 149. Qiagen Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 150. Qiagen Recent Development
Table 151. Siemens Heathcare Diagnostics Company Details
Table 152. Siemens Heathcare Diagnostics Business Overview
Table 153. Siemens Heathcare Diagnostics Product
Table 154. Siemens Heathcare Diagnostics Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 155. Siemens Heathcare Diagnostics Recent Development
Table 156. Roche Company Details
Table 157. Roche Business Overview
Table 158. Roche Product
Table 159. Roche Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 160. Roche Recent Development
Table 161. Roche(Ventana Medical Systems) Company Details
Table 162. Roche(Ventana Medical Systems) Business Overview
Table 163. Roche(Ventana Medical Systems) Product
Table 164. Roche(Ventana Medical Systems) Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 165. Roche(Ventana Medical Systems) Recent Development
Table 166. Trovagene Company Details
Table 167. Trovagene Business Overview
Table 168. Trovagene Product
Table 169. Trovagene Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 170. Trovagene Recent Development
Table 171. Vermillion Company Details
Table 172. Vermillion Business Overview
Table 173. Vermillion Product
Table 174. Vermillion Revenue in Cancer Test Business (2015-2020) (Million US$)
Table 175. Vermillion Recent Development
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Cancer Test Market Share by Type: 2020 VS 2026
Figure 2. Laboratory Tests Features
Figure 3. Genetic Tests Features
Figure 4. Imaging Features
Figure 5. Endoscopy Features
Figure 6. Global Cancer Test Market Share by Application: 2020 VS 2026
Figure 7. Bladder Cancer Test Case Studies
Figure 8. Breast Cancer Test Case Studies
Figure 9. Cervical Cancer Test Case Studies
Figure 10. Colorectal (Colon) Cancer Test Case Studies
Figure 11. Ovarian Cancer Test Case Studies
Figure 12. Prostate Cancer Test Case Studies
Figure 13. Liver Cancer Test Case Studies
Figure 14. Flow Cytometry Case Studies
Figure 15. Other Organ Specific Cancer Test Case Studies
Figure 16. Cancer Test Report Years Considered
Figure 17. Global Cancer Test Market Size YoY Growth 2015-2026 (US$ Million)
Figure 18. Global Cancer Test Market Share by Regions: 2020 VS 2026
Figure 19. Global Cancer Test Market Share by Regions (2021-2026)
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Cancer Test Market Share by Players in 2019
Figure 22. Global Top Cancer Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Test as of 2019
Figure 23. The Top 10 and 5 Players Market Share by Cancer Test Revenue in 2019
Figure 24. North America Cancer Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Europe Cancer Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. China Cancer Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Japan Cancer Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Southeast Asia Cancer Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. India Cancer Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Central & South America Cancer Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Abbott Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 33. Radient Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Radient Pharmaceuticals Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 35. BD Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. BD Diagnostics Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 37. Beckman Coulter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Beckman Coulter Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 39. BioCurex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. BioCurex Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 41. bioMerieux Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. bioMerieux Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 43. Cepheid Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Cepheid Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 45. CytoCore Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. CytoCore Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 47. DiagnoCure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. DiagnoCure Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 49. Gen-Probe Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Gen-Probe Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 51. Genomic Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Genomic Health Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 53. QIAGEN Marseille (Earlier Ipsogen) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. QIAGEN Marseille (Earlier Ipsogen) Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 55. Myriad Genetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Myriad Genetics Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 57. Panacea Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Panacea Pharmaceuticals Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 59. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Qiagen Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 61. Siemens Heathcare Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Siemens Heathcare Diagnostics Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 63. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Roche Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 65. Roche(Ventana Medical Systems) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Roche(Ventana Medical Systems) Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 67. Trovagene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Trovagene Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 69. Vermillion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Vermillion Revenue Growth Rate in Cancer Test Business (2015-2020)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed